Holifya raises €2M seed to scale AI-powered GLP-1 obesity care in Italy
What's the deal? HolifyaDealroom has a profile for this one. Try Dealroom →, an Italian startup, has raised €2 million in a seed round led by CDP Venture CapitalDealroom has a profile for this one. Try Dealroom → to expand its AI-powered GLP-1 obesity clinic in Milan.
What's the endgame? The company combines GLP-1 weight-loss drugs with AI-driven care to treat obesity. It plans to use the funding to grow its clinic and reach more patients.
Why now? Fewer than 1% of eligible Italians use GLP-1 drugs, compared with over 4% in the UK. That gap leaves room for services aimed at widening access.
The signal: The round ranks among the top 10% of all seed deals ever recorded in Italy, a sign of investor appetite for GLP-1-focused healthcare as the category expands across Europe.
Read more: Tech Funding News
Image credit: Holifya
